FDA
Norethindrone and Ethinyl Estradiol and Ferrous Fumarate
The FDA lists this product in 7 strengths and forms.
Indications
Norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable) are indicated for use by females of reproductive potential to prevent pregnancy.
- Norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable) are a progestin/estrogen COC indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )
Contraindications
Norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable) are contraindicated in females who are known to have or develop the following conditions:
- A high risk of arterial or venous thrombotic diseases. Examples include women who are known to:
- Smoke, if over age 35 [see Boxed Warning and Warnings and Precautions (5.1) ]
- Have deep vein thrombosis or pulmonary embolism, now or in the past [see Warnings and Precautions (5.1) ]
- Have inherited or acquired hypercoagulopathies [see Warnings and Precautions (5.1) ]
- Have cerebrovascular disease [see Warnings and Precautions (5.1) ]
- Have coronary artery disease [see Warnings and Precautions (5.1) ]
- Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see Warnings and Precautions (5.1) ]
- Have uncontrolled hypertension [see Warnings and Precautions (5.4) ]
- Have diabetes mellitus with vascular disease [see Warnings and Precautions (5.6) ]
- Have headaches with focal neurological symptoms or have migraine headaches with aura [see Warnings and Precautions (5.7) ]
- Women over age 35 with any migraine headaches [see Warnings and Precautions (5.7) ]
- Liver tumors, benign or malignant, or liver disease [see Warnings and Precautions (5.2) ]
- Undiagnosed abnormal uterine bleeding [see Warnings and Precautions (5.8) ]
- Pregnancy, because there is no reason to use COCs during pregnancy [see Warnings and Precautions (5.9) and Use in Specific Populations (8.1) ]



